Candid Health raised $120 million to go after one of healthcare's least glamorous but most expensive problems: medical billing. Fortune's July 22 report frames the addressable market at $280 billion -- the scale of revenue-cycle-management spend across US hospitals, physician groups and payers, most of it still running through a mix of legacy software and outsourced billing labor.
Revenue-cycle management has been ripe for automation for years, but the incumbents -- Waystar, R1 RCM, and the remnants of Change Healthcare now folded into UnitedHealth's Optum -- have been slow to rebuild their stacks around AI-native claims processing, coding and denial management. That gap is exactly what Candid Health and peers like Adonis and Anomaly are racing to fill, using large language models to read clinical documentation, generate accurate billing codes and predict which claims are likely to be denied before they're even submitted.
The $120 million round size puts Candid Health in the upper tier of healthtech infrastructure raises this year, alongside a broader pattern of investors backing 'boring but massive' AI automation plays over consumer-facing health apps. Denial management alone is a multi-billion-dollar cost center for US health systems -- claims get rejected for coding errors, missing documentation or payer-specific quirks, and providers often write off revenue rather than fight every denial.
Competitively, Candid Health has to prove it can out-execute both the legacy RCM vendors defending entrenched hospital contracts and a growing set of AI-native rivals chasing the same market. The bear case is that healthcare procurement cycles are notoriously slow and hospital systems are risk-averse about automating anything touching revenue, which means a $120 million round buys runway but not necessarily fast adoption.
For healthtech-focused investors, this is another data point that RCM automation is becoming one of the most heavily capitalized subsectors in AI-native healthcare -- worth watching which of these companies actually lands multi-year system-wide contracts with a major hospital network, versus which stay stuck in pilot purgatory.